Latest filing published 07 Nov 2025 for Evoke Pharma Inc, €46k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Roger M. Klein has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Charah Solutions, Inc. and Evoke Pharma Inc. In total, 4 filings cover trades dated from 2 June 2023 to 6 November 2025.
Both buying and selling appear: 3 purchases worth €42k, against 1 sale worth €46k. Netting one side against the other leaves €4,699 of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings no purchases and 1 sale.
In size, the median ticket on the buying side is €9,626. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 7 November 2025: an open-market sale of €46k, in Evoke Pharma Inc. The last purchase on record was published on 30 June 2023, which is 1,206 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 21 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations